Explore / Clinical trial
Clinical trial

Ketamine for Refractory Chronic Migraine: a Pilot Study

Thomas Jefferson UniversityCompletedEarly Phase 1Started Mar 22, 20196 enrolledUnited StatesNCT03896256

Abstract

Ketamine is a drug used for anesthesia but at low doses it is a very effective pain reliever in several chronic conditions. Preliminary studies have shown that ketamine might be effective for patients with refractory chronic migraine, which is a severe type of headache for which patients usually have tried and failed many medications and can cause severe disability to their lives. This study will evaluate ketamine prospectively when given to patients who have "failed" an initial inpatient treatment.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetaminePain

Keywords

Migraine Headache With Intractable Migraine

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.